BEAT (HeartBeam Inc) רווח למניה בארבעת הרבעונים האחרונים

HeartBeam, Inc. (BEAT) relies on external investment due to slow product time-to-market and bureaucratic certification delays. Despite domestic demand in the US, the company is susceptible to global logistics disruptions when procuring chips. This chart illustrating the market valuation of EPS (TTM) at 37.60 underscores the company's status as an innovator in creating mobile 3D ECG systems trusted by physicians.
BEAT (heartbeam.com): פילוחים אנליטיים ודוחות לפי אינדיקטורים

Year-over-year (YoY) EPS growth (TTM) measures the dynamics of net income per share over a rolling twelve-month period, reflecting the actual efficiency of the business capitalization. Analyzing the percentage growth of earnings per share YoY over 12 months allows for the filtering of random noise and an assessment of HeartBeam, Inc. (BEAT) resilience to manufacturing outsourcing risks and dependence on external clinical trials.